C33Nab-paclitaxel (Nab-P) in HER2-ve advanced breast cancer...

Annals of Oncology 2017 / 10 Vol. 28; Iss. suppl_6

C33Nab-paclitaxel (Nab-P) in HER2-ve advanced breast cancer (ABC) patients (pts): focus on luminal cancers. Results from GIM13 - AMBRA study

Mustacchi, G, Cazzaniga, M, Giordano, M, Garrone, O, Donadio, M, Del Mastro, L, Livi, L, Natoli, C, Michelotti, A, Turletti, A, Riccardi, F, Marchetti, P, Montemurro, F, Romagnoli, E, De Placido, S, B
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx424.032
Date:
October, 2017
File:
PDF, 51 KB
english, 2017
Conversion to is in progress
Conversion to is failed